Journal of the National Cancer Institute Advance Access originally published online on April 8, 2008
JNCI Journal of the National Cancer Institute 2008 100(8):519; doi:10.1093/jnci/djn136
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2008.
MEMO TO THE MEDIA |
High-Intensity Chemotherapy Does Not Improve Survival in Small Cell Lung Cancer
jncimedia@oxfordjournals.org
301-841-1287
| The first 10% of the full text of this article appears below. |
Small cell lung cancer (SCLC) patients treated with high-dose chemotherapy did not have better survival rates than those treated with standard doses, according to a randomized controlled trial published online April 8 in the Journal of the National Cancer Institute.
SCLC
Contact:
Note to Reporters:
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. H. Q. Heng The Conflict Between Complex Systems and Reductionism JAMA, October 1, 2008; 300(13): 1580 - 1581. [Full Text] [PDF] |
||||
